Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ROSIGLITAZONE Cause Aortic valve incompetence? 22 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 22 reports of Aortic valve incompetence have been filed in association with ROSIGLITAZONE. This represents 0.1% of all adverse event reports for ROSIGLITAZONE.

22
Reports of Aortic valve incompetence with ROSIGLITAZONE
0.1%
of all ROSIGLITAZONE reports
2
Deaths
18
Hospitalizations

How Dangerous Is Aortic valve incompetence From ROSIGLITAZONE?

Of the 22 reports, 2 (9.1%) resulted in death, 18 (81.8%) required hospitalization.

Is Aortic valve incompetence Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ROSIGLITAZONE. However, 22 reports have been filed with the FAERS database.

What Other Side Effects Does ROSIGLITAZONE Cause?

Myocardial infarction (17,018) Cardiac failure congestive (15,085) Cerebrovascular accident (7,899) Coronary artery disease (4,982) Acute myocardial infarction (2,437) Cardiac disorder (1,732) Coronary arterial stent insertion (1,698) Coronary artery bypass (1,181) Chest pain (990) Myocardial ischaemia (970)

What Other Drugs Cause Aortic valve incompetence?

FENFLURAMINE (136) SACUBITRIL\VALSARTAN (111) ADALIMUMAB (106) PANTOPRAZOLE (80) AMLODIPINE (79) BISOPROLOL (78) ASPIRIN (71) FUROSEMIDE (68) APIXABAN (66) METHOTREXATE (65)

Which ROSIGLITAZONE Alternatives Have Lower Aortic valve incompetence Risk?

ROSIGLITAZONE vs ROSUVASTATIN ROSIGLITAZONE vs ROSUVASTATIN\ROSUVASTATIN ROSIGLITAZONE vs ROTIGOTINE ROSIGLITAZONE vs ROXADUSTAT ROSIGLITAZONE vs ROXICODONE

Related Pages

ROSIGLITAZONE Full Profile All Aortic valve incompetence Reports All Drugs Causing Aortic valve incompetence ROSIGLITAZONE Demographics